EUVIMED · CrossrefJournal
Metabolism and Target Organ Damage
ISSN 2769-6375 · OAE Publishing Inc.
Latest articles
Macrophage ferroptosis in atherosclerosis: unraveling novel antiatherogenic targets and pharmacological strategies
Immune cell-resolved genetic associations nominate FADS1 as a candidate locus in metabolic syndrome
Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain
Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications
Lean MAFLD as a distinct phenotype
Advances in the non-invasive assessment of metabolic dysfunction-associated steatotic liver disease
Fibroblast growth factor 19/15-mediated metabolic regulation supports its drug development potential: a narrative review
Multimorbidity comes to roost: insights from the LiverScreen project on the future burden of metabolic liver disease
Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response
Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density
Determinants of plasma branched-chain amino acids and associations with cardiometabolic biomarkers and proteomic signatures
Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD)
Liver muscle bone axis in metabolic dysfunction-associated steatotic liver disease
Estimation of liver fibrosis and cirrhosis risk using non-invasive biomarkers in people living with HIV and prediabetes in Tanzania
Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation
CagriSema: a novel dual-pathway approach to target obesity and its complications
MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture
The application of GLP-1 receptor agonists in obesity due to MC4R deficiency
Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes
Lipid-associated macrophages in metabolic dysfunction-associated steatotic liver disease: immune regulation of lipid burden
History of gestational diabetes mellitus or hypertensive disorders of pregnancy and risk of chronic kidney disease
Incretin-based therapy for MASH: are two better than one?
Pharmacologic management of metabolic and alcohol-associated liver disease
Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury
Podocyte lipotoxicity in diabetic kidney disease: mechanisms and targets
Mechanism-driven therapy for diabetic cardiovascular disease
Wilson disease revisited: is the gut a metabolically vulnerable target organ?
Variation spectrum and reevaluation of selected VUS of ATP7B in a Chinese Wilson disease cohort
Sex and age genetic overlap between body mass index and attention deficit hyperactivity disorder in twins
Navigating gut-liver metabolic homeostasis: the role of the autonomic nervous system
EUVIMED